In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
"I think we’ll do it February 1st." On the morning of January 28, Detroit Big Three automaker General Motors (GM) reported Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback